Research

February 22, 2020

Pharmacologic Therapies for Aortic Stiffness in End-Stage Renal Disease: A Systematic Review and Meta-Analysis

Most pharmacologic interventions that target aortic stiffness in renal disease are associated with mixed effects to vascular function. A team led by Agharazii conducted a meta-analysis to determine which targeted aortic stiffness therapies improve PWV and SBP measures. Multiple therapies, vitamin D and renin angiotensin system inhibitors, did not show any added benefit than placebo groups. However, calcium channel blockers showed a controlled decrease of both PWV and SBP beyond standard care. This indicates that incorporating this therapy could have reduced cardiovascular burden within renal affected cohorts. 

Get in Touch

If you are an existing customer that needs assistance, please visit our Customer Portal.

Cardiex Quote Request

Fill out the form below and we'll get back to you with a personalized quote based on the products you're interested in.

Please Select Product